SydneyAI startup Lorikeet has raised another US$9 million (A$14m), just four months after pocketing a $7.3 million Seed round. This time Blackbird led the round, joined by existing investors Square ...

The news: Clinical-stage radiopharmaceutical company AdvanCell has completed an oversubscribed Series C financing round of $US112 million ($171 million), co-led by SV ...

SYDNEY--(BUSINESS WIRE)--AdvanCell, a clinical-stage radiopharmaceutical company developing innovative cancer therapeutics, today announced the successful completion of an oversubscribed US$112 millio ...

AdvanCell, a clinical-stage radiopharmaceutical company developing innovative cancer therapeutics, today announced the successful completion of an oversubscribed US$112 million Series C financing.

Gift 5 articles to anyone you choose each month when you subscribe. Australian technology start-ups received an increased $4 billion of venture capital funding in 2024, with a quarter of the money ...

AdvanCell announced the successful completion of an oversubscribed $112 million (US) Series C financing, making it the only Australian radiopharma company that has cash to burn. This milestone funding ...

AdvanCell, a clinical-stage radiopharmaceutical company developing innovative cancer therapeutics, today announced the successful completion of an oversubscribed US$112 million Series C financing.

AdvanCell, an Australia-based radiopharmaceutical company, has raised $112m as investor interest in the radiopharma sector continues in 2025. The funding round was co-led by SV Health Investors ...

SYDNEY--(BUSINESS WIRE)--AdvanCell, a clinical-stage radiopharmaceutical company developing innovative cancer therapeutics, today announced the successful completion of an oversubscribed US$112 ...